European Health Forum Gastein 2016: ECDC workshop discusses life-course vaccination approaches and challenges
The aim of this workshop was to prompt reflection among key stakeholders on the benefits and challenges of implementing a life-course approach to vaccination.
When discussing vaccination, it is common to focus on immunisation of children. However, the changes in the EU’s demographic structure, with growing life expectancy, and the contribution of vaccinating older generations to healthy aging, have determined a growing interest in research and strategic approaches to life-course vaccination.
In this context, ECDC organised a workshop at the European Health Forum Gastein (EHFG) 2016 with the aim of prompting reflection among key stakeholders on the benefits and challenges of implementing a life-course approach to vaccination. The workshop took place on 29th September 2016. It was chaired by the ECDC Acting Director Andrea Ammon, and speakers include representatives from the ECDC, the European Commission, the UK Public Health England, the Dutch Ministry of Health and the University Hospital of Grenoble in France
The workshop’s programme featured presentations on the state of play of life-course vaccination in EU countries, knowledge gaps and challenges, ongoing activities at EU level, impact of adult vaccination on healthy aging, and practical experiences from countries in implementing life-course vaccination. Presentations were followed by a panel discussion and a question and answers session.
World Health Organization recommendations for the influenza virus vaccine composition for the 2020 southern hemisphere season
11 Oct 2019 - On September 2019, WHO has agreed on the recommended composition of the quadrivalent and trivalent influenza vaccines for the southern hemisphere 2020 influenza season.
ECDC: Insufficient vaccination coverage in EU/EEA fuels continued measles circulation
28 May 2019 - A large measles epidemic has affected the EU/EEA Member States in the past three years, with 44 074 cases reported by 30 Member States between 1 January 2016 and 31 March 2019.
WHO recommendations for influenza virus vaccine composition for the 2019–2020 northern hemisphere season
1 Mar 2019 - On 18–20 February 2019, the World Health Organization (WHO) agreed on the recommended composition of the quadrivalent influenza vaccine for the northern hemisphere 2019–2020 influenza season: an A/Brisbane/02/2018 (H1N1)pdm09-like virus, an A(H3N2) virus component to be announced on 21 March 2019, a B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage) and a B/Phuket/3073/2013-like virus (B/Yamagata/16/88 lineage).